• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC CARTO 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC CARTO 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE Back to Search Results
Catalog Number FG540000
Device Problem Display or Visual Feedback Problem (1184)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/08/2024
Event Type  malfunction  
Manufacturer Narrative
The hardware investigation has begun but it has not been completed at this time.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
 
Event Description
It was reported that a patient underwent an atrial fibrillation ablation procedure with a carto 3 system and while the patient was intubated and mapping in the left atrium occurred, there was a map shift on the carto.There was no error on the system.The map shift was discovered when ablation started, and the catheter vector did not correspond to the expected vector at the location seeing on the map.A coronary sinus (cs) snapshot was also used to notice the shift.The issue was seen during ablation.The approximate difference in catheter location before and after map shift was about the distance between the tip and the proximal electrodes on the thermocool smarttouch catheter.No cardioversion was performed during the case and no patient movement was noticed.It is unknown how the issue was resolved.But it was confirmed that the procedure continued.No patient consequences were reported.
 
Manufacturer Narrative
On 1-may-2024, the product investigation was completed.It was reported that a patient underwent an atrial fibrillation ablation procedure with a carto 3 system and while the patient was intubated and mapping in the left atrium occurred, there was a map shift on the carto.There was no error on the system.The map shift was discovered when ablation started, and the catheter vector did not correspond to the expected vector at the location seeing on the map.A coronary sinus (cs) snapshot was also used to notice the shift.The issue was seen during ablation.The approximate difference in catheter location before and after map shift was about the distance between the tip and the proximal electrodes on the thermocool smarttouch catheter.No cardioversion was performed during the case and no patient movement was noticed.It is unknown how the issue was resolved.But it was confirmed that the procedure continued.No patient consequences were reported.Device evaluation details: the manufacturer investigated the issue.It was confirmed that the issue was resolved by reimaging the carto 3 workstation.The system is ready for use.It was found that the reported issue is related to patient movement - user error.According to carto 3 instructions for use, (p.N.Ug-5400-007h, rev.00a ): "when the relative position between the patches remains the same but the position of the heart relative to the back patches has changed (for example, after repositioning the patient's head on a pillow or moving the patient's arm without changing the patient's position on the mattress, or after the patient is cardioverted), the system will not give a warning and an incorrect map (map shift) might be generated." the manufacturing record evaluation was performed on carto 3 #34744, and no internal actions related to the reported complaint condition were identified.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO 3 SYSTEM
Type of Device
COMPUTER, DIAGNOSTIC, PROGRAMMABLE
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER (ISRAEL) LTD.
4 hatnufah street
yokneam 20667 17
IS   2066717
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key19053743
MDR Text Key340452890
Report Number2029046-2024-01143
Device Sequence Number1
Product Code DQK
UDI-Device Identifier10846835000870
UDI-Public10846835000870
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K133916
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 05/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberFG540000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 03/12/2024
Initial Date FDA Received04/05/2024
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/29/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/29/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
THERMOCOOL SMARTTOUCH
-
-